Piriform Cortex Ablation Volume Is Associated With Seizure Outcome in Mesial Temporal Lobe Epilepsy

Brian Y Hwang1, David Mampre1, Yohannes K Tsehay1

  • 1Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Neurosurgery
|May 20, 2022
PubMed
Abstract

Insights

Ablating the piriform cortex during MR-guided laser interstitial thermal therapy (MRgLITT) for mesial temporal lobe epilepsy (mTLE) is linked to better seizure outcomes. This suggests the piriform cortex is a key target for effective seizure control.

Area of Science:

  • Neurosurgery
  • Epilepsy Research
  • Medical Technology

Background:

  • Mesial temporal lobe epilepsy (mTLE) is a common form of drug-resistant epilepsy.
  • Piriform cortex resection during anterior temporal lobectomy improves seizure outcomes in mTLE.
  • The role of piriform cortex ablation in MR-guided laser interstitial thermal therapy (MRgLITT) for mTLE is not well-defined.

Purpose of the Study:

  • To investigate the association between piriform cortex ablation and seizure outcomes in mTLE patients treated with MRgLITT.
  • To evaluate the piriform cortex as a potential target for improving seizure control in mTLE.

Main Methods:

  • Volumetric analyses of hippocampus, amygdala, and piriform cortex were performed pre- and post-MRgLITT.
  • Thirty-nine mTLE patients undergoing MRgLITT between 2014 and 2019 were analyzed.
  • Logistic regression models (univariate and multivariable) assessed the relationship between ablation volumes and seizure outcomes (ILAE class 1 at 6 months and 1 year).

Main Results:

  • Percent piriform cortex ablation was significantly associated with International League Against Epilepsy (ILAE) class 1 seizure outcome at 6 months (OR 1.051, P = .045).
  • In multivariable analysis, piriform cortex ablation independently predicted seizure freedom at 6 months (OR 1.085, P = .019) and 1 year (OR 1.074, P = .041).
  • Ablation volume was associated with seizure freedom at 1 year, but percent amygdala and hippocampus ablation were not significant predictors.

Conclusions:

  • Piriform cortex ablation volume is a significant predictor of seizure outcome in mTLE patients treated with MRgLITT.
  • The piriform cortex should be considered a high-yield target for MRgLITT to achieve favorable seizure outcomes in mTLE.